Vanguard Plus 5 L4 CV Canine Multi-Antigen Vaccine

فانجارد بلس 5 إل 4 سي في لقاح الكلاب الشامل للوقاية من الدستمبر والبارفو والكورونا والليبتوسبيرا الرباعية

Compare
Biological

Vanguard Plus 5 L4 CV is a multi-component vaccine containing modified-live cultures of canine distemper, adenovirus type 2 (CAV-2), parainfluenza, and high-titer parvovirus (CPV-2b), inactivated canine coronavirus, and whole-cell inactivated bacterins of Leptospira canicola, L. grippotyphosa, L. icterohaemorrhagiae, and L. pomona. Indicated for the vaccination of healthy dogs 6 weeks of age or older.

Dosage Form

N/A

Product Type

Biological

Manufacturer

Zoetis

Package

Cartons of 25 x 1-dose vials with sterile liquid diluent (1 mL each)

Dosages

Species Dosage Route Duration
Dog 1 mL administered subcutaneously Subcutaneous (SC) Initial series of 3 doses administered 3 weeks apart starting at 6 to 8 weeks of age; revaccinate annually with 1 dose

Withdrawal Periods

No withdrawal information available.

Indications

  • Vaccination of healthy dogs 6 weeks of age or older as an aid in preventing canine distemper, infectious canine hepatitis (CAV-1), respiratory disease (CAV-2), canine coronavirus, canine parainfluenza, canine parvovirus (CPV-2b), and leptospirosis (L. canicola, L. grippotyphosa, L. icterohaemorrhagiae, L. pomona).

Contraindications

  • Do not vaccinate clinically ill or febrile dogs. Do not use in pregnant bitches.

Precautions

  • Contains gentamicin as preservative. Epinephrine should be administered if anaphylaxis occurs.

Side Effects

  • Mild temporary pain or swelling at the injection site; transient lethargy.

Images

Documents

  • Vanguard Plus 5 L4 CV Canine Multi-Antigen Vaccine Prescribing Information

    Leaflet
    Download

This website uses cookies to ensure you get the best experience.